Nanoknife
Showing 1 - 25 of 60
Unresectable Pancreatic Cancer Trial in Baltimore (NanoKnife IRE System)
Active, not recruiting
- Unresectable Pancreatic Cancer
- NanoKnife IRE System
-
Baltimore, MarylandUniversity of Maryland Medical Center
Jan 30, 2023
Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)
Not yet recruiting
- Liver Metastasis Colon Cancer
- IRE plus checkpoint inhibitor
- IRE plus Checkpoint Inhibitor plus CpG-ODN
- (no location specified)
Sep 13, 2023
Prostate Cancer Trial in United States (Irreversible Electroporation)
Recruiting
- Prostate Cancer
- Irreversible Electroporation
-
Aurora, Colorado
- +6 more
Jul 6, 2022
Pancreatic Adenocarcinoma, Interventional Imaging Trial in Poitiers (NanoKnife)
Completed
- Pancreatic Adenocarcinoma
- Interventional Imaging
- NanoKnife
-
Poitiers, FranceCHU Poitiers
Mar 29, 2022
Pancreatic Ductal Adenocarcinoma Trial in Toronto (Irreversible Electroporation, NanoKnife System)
Completed
- Pancreatic Ductal Adenocarcinoma
- Irreversible Electroporation
- NanoKnife System
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Aug 10, 2022
Pancreas Cancer, Metastatic Trial in Aalborg (Pembrolizumab, Irreversible electroporation)
Active, not recruiting
- Pancreas Cancer, Metastatic
- Pembrolizumab
- Irreversible electroporation
-
Aalborg, North Denmark Region, DenmarkDepartment of Oncology
Mar 8, 2022
Colorectal Liver Metastases Trial in Amsterdam, Leiden (Irreversible electroporation (IRE))
Completed
- Colorectal Liver Metastases
- Irreversible electroporation (IRE)
-
Amsterdam, Noord-Holland, Netherlands
- +2 more
Dec 18, 2022
Breast Cancer Trial in Guangzhou (NanoKnife LEDC System)
Completed
- Breast Cancer
- NanoKnife LEDC System
-
Guangzhou, Guangdong, ChinaFUDA Cancer Hospital
Sep 1, 2021
Pancreatic Cancer Trial in Guangzhou (NanoKnife LEDC System)
Completed
- Pancreatic Cancer
- NanoKnife LEDC System
-
Guangzhou, Guangdong, ChinaFUDA Cancer Hospital
Sep 1, 2021
Extremities Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Extremities Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Gallbladder Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Gallbladder Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Laryngeal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Laryngeal Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Esophageal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Esophageal Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Stomach Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Stomach Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Uterine Cervical Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Uterine Cervical Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Hilus Pulmonary Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Hilus Pulmonary Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Urinary Bladder Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Urinary Bladder Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Head and Neck Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Head and Neck Neoplasms
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Renal Pelvic and Ureteral Tumors Trial in Guangzhou (rreversible electroporation (IRE), NanoKnife)
Completed
- Renal Pelvic and Ureteral Neoplasms
- rreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Lymph Node Metastases Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Lymph Node Metastases
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Lung Tumors Accompanied by Respiratory Function Insufficiency Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)
Completed
- Lung Neoplasms Accompanied by Respiratory Function Insufficiency
- Irreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Pancreatic Cancer & Surgical Resection
Recruiting
- Pancreas Cancer
- NanoKnife procedure
-
Dallas, TexasLiver Institute of Methodist Dallas Medical Center
Feb 3, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Moscow (Focal irreversible electroporation of the prostate cancer)
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Focal irreversible electroporation of the prostate cancer
-
Moscow, Russian FederationInstitute for Urology and Reproductive Health, Sechenov Universi
Jul 21, 2021
Hepatic Carcinoma Trial in Guangzhou (NanoKnife LEDC System)
Completed
- Hepatic Carcinoma
- NanoKnife LEDC System
-
Guangzhou, Guangdong, ChinaFUDA Cancer Hospital
Sep 1, 2021
Liver Cancer Trial in Guangzhou (Irreversible electroporation (IRE))
Completed
- Liver Cancer
- Irreversible electroporation (IRE)
-
Guangzhou, Guangdong, ChinaFUDA Cancer Hospital
Sep 1, 2021